Skip to content
DataLookout
Menu

NCT07924462

Chronic Respiratory Disease Participant Engagement Study

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Number of patients indicating willingness to be re-contacted for future clinical trials
Timeframe: Until the end of the study (up to 5 weeks)]
Participation feedback questionnaire results using Participant Feedback and Clinical Research Experience Questionnaire
Timeframe: Until the end of the study (up to 5 weeks)]

Secondary (17)

Clinical baseline characterisation of medical history
Clinical baseline characterisation of exacerbation history
Clinical baseline characterisation of smoking status
Clinical baseline characterisation of concomitant medications (con-meds)
Clinical baseline characterisation of respiratory rate
Show 12 moreShow less
Clinical baseline characterisation of body temperature
Clinical baseline characterisation of pulse rate
Clinical baseline characterisation of oxygen saturation
Clinical baseline characterisation of blood pressure
Clinical baseline characterisation of Lung function for FEV1 parameter
Clinical baseline characterisation of Lung function for FVC parameter
Clinical baseline characterisation of Lung function for FEV1/FVC ratio
Clinical baseline characterisation of oxygen use
Clinical baseline characterisation of bloods including genetic testing where clinically indicated and imaging data where available.
Number and proportion of new diagnoses following assessment
Factors associated with underdiagnosis by exploring differences between patient-reported outcomes and clinical data, including potential variations by age, sex and ethnicity
Differences in patient-reported outcome scores between chronic respiratory disease subgroups using EQ-5D-5L together with the EQ Visual Analogue Scale (EQ VAS)

Arms and interventions

Group 1

Sites

1 site in 1 country

  • Richmond Pharmacology LimitedLondon, United Kingdom